Transformation of EML4-ALK fusion-positive adenocarcinoma into squamous cell carcinoma in association with acquired resistance to crizotinib

doi:10.1016/j.lungcan.2020.01.001

科研成果详情

题名	Transformation of EML4-ALK fusion-positive adenocarcinoma into squamous cell carcinoma in association with acquired resistance to crizotinib
作者	Fenfang Wang 1; Jing Qin 2; Fajun Xie 2; Qihuan Wu 3; Hongyang Lu 4
发表日期	2020-02-01
发表期刊	Lung cancer (Amsterdam, Netherlands) 影响因子和分区
语种	英语
原始文献类型	Case Reports ; Letter ; Research Support, Non-U.S. Gov't
出版者	ELSEVIER IRELAND LTD
ISSN	0169-5002
EISSN	1872-8332
卷号	140 页码:118-120.
DOI	10.1016/j.lungcan.2020.01.001
页数	3
WOS类目	Oncology ; Respiratory System
WOS研究方向	Oncology ; Respiratory System
WOS记录号	WOS:000510532900019
收录类别	PUBMED ; SCIE
URL	查看原文
Pubmed记录号	31924369
通讯作者地址	[Lu, Hongyang]Chinese Acad Sci, ICBM, Hangzhou 310022, Peoples R China.
引用统计	被引频次：3[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/33434
专题	研究生工作部（研究生院）
作者单位	1.Department of Medical Oncology, Xiangshan First People&s Hospital, Xiangshan, 315700, PR China; Graduate School, Wenzhou Medical University, Wenzhou, 325035, PR China.; 2.Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, 310022, PR China; Department of Thoracic Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences, 310022, PR China; Zhejiang Key Laboratory of Diagnosis & Treatment Technology on Thoracic Oncology (Lung and Esophagus), Zhejiang Cancer Hospital, 310022, PR China.; 3.Department of Medical Emergency, Xiangshan First People&s Hospital, Xiangshan, 315700, PR China.; 4.Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, 310022, PR China; Department of Thoracic Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences, 310022, PR China; Zhejiang Key Laboratory of Diagnosis & Treatment Technology on Thoracic Oncology (Lung and Esophagus), Zhejiang Cancer Hospital, 310022, PR China.
第一作者单位	研究生工作部; 附属象山医院（象山县第一人民医院）
第一作者的第一单位	研究生工作部
推荐引用方式 GB/T 7714	Fenfang Wang,Jing Qin,Fajun Xie,et al. Transformation of EML4-ALK fusion-positive adenocarcinoma into squamous cell carcinoma in association with acquired resistance to crizotinib[J]. Lung cancer (Amsterdam, Netherlands),2020,140:118-120..
APA	Fenfang Wang, Jing Qin, Fajun Xie, Qihuan Wu, & Hongyang Lu. (2020). Transformation of EML4-ALK fusion-positive adenocarcinoma into squamous cell carcinoma in association with acquired resistance to crizotinib. Lung cancer (Amsterdam, Netherlands), 140, 118-120..
MLA	Fenfang Wang,et al."Transformation of EML4-ALK fusion-positive adenocarcinoma into squamous cell carcinoma in association with acquired resistance to crizotinib".Lung cancer (Amsterdam, Netherlands) 140(2020):118-120..